Immunome Inc (IMNM)
15.50
+0.03
(+0.19%)
USD |
NASDAQ |
May 10, 16:00
15.50
0.00 (0.00%)
After-Hours: 20:00
Immunome Profit Margin (Quarterly): -2.42K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.42K% |
September 30, 2023 | -121.9% |
Date | Value |
---|---|
June 30, 2023 | -130.4% |
March 31, 2023 | -180.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.42K%
Minimum
Dec 2023
-121.9%
Maximum
Sep 2023
-713.5%
Average
-155.5%
Median
Profit Margin (Quarterly) Benchmarks
Ayala Pharmaceuticals Inc | -- |
Tenax Therapeutics Inc | -- |
GE HealthCare Technologies Inc | 8.04% |
Exelixis Inc | 8.78% |
Puma Biotechnology Inc | -11.00% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -322.1% |
Return on Assets | -129.0% |
Return on Invested Capital | -286.4% |
Operating Margin (Quarterly) | -362.0% |
Return on Net Operating Assets | -3.07K% |